Liver mass pathophysiology

Liver Mass Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differential Diagnosis
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
Evaluation of Liver Mass
Staging
History and Symptoms
Physical Examination
Laboratory Studies
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Case Studies
Case #1
Liver mass pathophysiology On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Liver mass pathophysiology All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Liver mass pathophysiology
CDC on Liver mass pathophysiology
Liver mass pathophysiology in the news
Blogs on Liver mass pathophysiology
Directions to Hospitals Treating bone or soft tissue mass
Risk calculators and risk factors for Liver mass pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Iqra Qamar M.D.[2]

Gross Pathology

	Pathogeneis	Genetics	Associated conditions	Gross Pathology	Microscopic Pathology
Hepatocellular adenoma	Estrogens cause the transformation of hepatocytes via steroid receptors Results in generalized vascular ectasia	Transcription factor 1 gene (TCF1) Interleukin 6 signal transducer gene (IL6ST) β catenin-1 gene (CTNNB1)	Glycogen storage disease types Ia and III Fanconi anemia Thalassemia Familial adenomatous polyposis Familial diabetes mellitus Hurler disease Galactosemia	Well circumscribed Nonlobulated Smooth and soft White to yellow to brown lesions	Cords of hepatocytes that have a high glycogen and fat content Lack of normal hepatic parenchymal architecture Absence of portal tracts and hepatic veins
Focal nodular hyperplasia	Develop around a preexisting arterial malformation Production of growth factors promote growth of small arteries  Increased perfusion of the adjacent tissue results in peritumoral hyperplasia.	β-catenin gene (CTNNB1) TP53 APC or HNF1α	Klippel-Trénaunay-Weber syndrome	Well-circumscribed Non-encapsulated Central fibrous scar	Hepatic parenchyma arranged in incomplete nodules Fibrous tissue with thick-walled vessels Bile ductular proliferation Cells of chronic inflammation
Intrahepatic bileduct cystadenoma
Hemangioma	Congenital disorder Vascular malformations that enlarge by ectasia  Estrogen and progesterone influence over tumor growth More common in females		Von Hippel Lindau disease	Well-circumscribed Appear red-brown Solitary nodules Less than 5cms	Large cystically dilated vessels Thin walls Intravascular thrombosis Calcifications
Hepatic Cyst	Von Meyenburg complexes separate from biliary tree and dilate to form cyst			Single, unilocular cyst Variable amounts of clear amber fluid (may contain blood, bile, mucus, pus)	Lined by flat / cuboidal epithelium Epithelium rests on thin collagenous wall without spindle cell stroma Degenerative changes include epithelial desquamation, multiloculation, calcification
Lymphangioma
Lymphangiomatosis
Angiomyolipoma
HCC			HBV infection HCV infection Underlying cirrhotic liver disease Inflammation Necrosis and fibrosis of the liver
Cholangiocarcinoma
Hepatic abscess
Parasitic cysts